All News

Image of February 2026 cover art for Diabetes created by Christopher Wilson, PhD.
January 14, 2026

Research reveals B cells’ more sinister role in progression of Type 1 diabetes

B cells are immune cells thought to drive the immune system’s attack on insulin-producing beta cells by activating anti-islet T cells.

Kascey Malone, CST; Brandon Petree, MD; Aaron Williams, MD; Yatrik Patel, MD; and Sean Bunch, RN; work around a patient during a heart transplant surgery. (photo by Erin O. Smith)
January 14, 2026

Vanderbilt Transplant Center nation’s largest after performing record number of solid organ transplants in 2025

Through dramatic growth, the VTC is now the largest transplant center in the country by volume, according to data from the United Network for Organ Sharing.

Some members of the Critical Care Outreach Team at Vanderbilt University Hospital include, front row, left to right, Casey Ernfelt, ACNP, Lindsay Trantum, ACNP, Rebekah Pike, ACNP. Back row, left to right, Liza Weavind, MBBCh, Cody Bowers, AG-ACNP, Kipp Shipley, DNP, Megan Shifrin, DNP, ACNP-BC, and Christopher Hughes, MD. (photo by Donn Jones)
January 13, 2026

Critical Care Outreach Team’s rapid response interventions improve patient safety, prevent ICU transfers

Since January 2020, members of the VUH CCOT have responded to more than 10,000 rapid response calls in every non-ICU unit in the adult hospital.

January 12, 2026

Pablo Juárez named president-elect of the Association of University Centers on Disabilities

Juárez’s election to this role reflects his long-standing commitment to innovation in the field of intellectual and developmental disabilities.

January 12, 2026

Guide published for outpatient cancer treatment with bispecific antibodies

Vanderbilt-Ingram was among the first in the nation to establish outpatient protocols for another personalized immunotherapy, CAR-T.

January 9, 2026

Weight loss drugs and bariatric surgery improve the body’s fat ‘balance:’ study

The retrospective study analyzed the electronic health records of 1,257 patients ages 18 to 65 who underwent bariatric surgery at Vanderbilt Health from 2017 to 2022, and 1,809 patients treated with the drugs semaglutide or tirzepatide from 2018 to 2023.